A Brighter Future for Livie
November 14, 2019
Thanks to a groundbreaking treatment, children who once faced inevitable blindness now have a chance to regain—and retain—their sight.
Content related to Children’s Hospital Los Angeles has treated 14 patients with Retinal Degeneration Using Gene Therapy
The Petersen Foundation Endowment Supports Three Signature Programs at CHLA
June 27, 2020
A generous endowment will help fund clinical care and research in the Cancer and Blood Disease Institute, The Vision Center and Inpatient Rehabilitation.
Faculty Spotlight: Aaron Nagiel, MD, PhD
March 19, 2022
Dr. Nagiel is investigating retinal development—studying exactly how photoreceptors connect with bipolar cells, the next downstream cells in the system.
Surgeons at Children’s Hospital Los Angeles Treat the Hospital’s First Patient with Gene Therapy
March 20, 2018
On March 20, 2018, surgeons at Children's Hospital Los Angeles, treated the hospital’s first patient with gene therapy. The complex eye surgery was performed by dedicated retina specialist, Aaron
Meet Some of our Research Staff Members
September 3, 2021
Amber Medina Clinical Research Coordinator Amber helps coordinate leukemia and lymphoma trials. Though she has been doing clinical research for 15 years, Amber came to CHLA just two years ago. Joining
Honor Roll… On a Roll! Children's Hospital Los Angeles Again Ranks No. 1 Children's Hospital in the West, No. 6 in the U.S.
June 25, 2018
For the second straight year, Children's Hospital Los Angeles (CHLA) has been named the top pediatric hospital in the western United States and No. 6 nationwide, according to U.S. News & World Report
Combination Therapy May Offer Better Outcomes for Patients with Retinoblastoma
April 19, 2016
Cultured retinoblastoma tumor containing tumor cells (red) and fibroblasts (green). Researchers at The Saban Research Institute of Children’s Hospital Los Angeles (CHLA) have demonstrated that
Identified Molecular Markers Will Bring Precision to Treatment of Retinoblastoma
September 23, 2022
New genes implicated in disease create new therapeutic targets and ability to assess disease severity.
Unique Next Generation Sequencing-Based Panel Designed for Pediatric Cancer Research
February 18, 2016
Children’s Hospital Los Angeles (CHLA) and Thermo Fisher Scientific have agreed to develop a next-generation sequencing (NGS)-based panel designed specifically for pediatric cancer research. The assay